Creative Planning
- SEC CIK
- 0001540235
- Latest filing
- Aug 13, 2026
GALT holding history
Galectin Therapeutics Inc in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GALT overviewAll 13F holders of GALTFull Q2 2026 holdings
- Shares (Q2 2026)
- 10,539
- Value
- $48.9K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 10,539 | $48.9K | <0.1% | +54+0.5% | Added | Holders |
| Q1 2026 | 10,485 | $29.3K | <0.1% | −780−6.9% | Reduced | Holders |
| Q4 2025 | 11,265 | $46.9K | <0.1% | +880+8.5% | Added | Holders |
| Q3 2025 | 10,385 | $44.0K | <0.1% | +10,385 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −24,214−100.0% | Sold out | Holders |
| Q1 2024 | 24,214 | $57.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 24,214 | $40.2K | <0.1% | +4,000+19.8% | Added | Holders |
| Q3 2023 | 20,214 | $38.8K | <0.1% | −834−4.0% | Reduced | Holders |
| Q2 2023 | 21,048 | $30.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 21,048 | $44.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 21,048 | $23.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 21,048 | $34.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 21,048 | $28.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 21,048 | $34.0K | <0.1% | +10,000+90.5% | Added | Holders |
| Q4 2021 | 11,048 | $23.0K | <0.1% | +11,048 | New | Holders |